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The genetic demyelinating mouse “twitcher” is a model of the
human globoid cell leukodystrophy, caused by galactosylcer-
amidase (GALC) deficiency. Demyelination in the twitcher brain
is secondary to apoptotic death of oligodendrocytes (OLs).
Lipocalin-type prostaglandin (PG) D synthase (L-PGDS), a pro-
tein expressed in mature OLs, was progressively upregulated in
twitcher OLs; whereas expression of OL-associated proteins
such as carbonic anhydrase II, myelin basic protein, and
myelin-associated glycoprotein was downregulated during de-
myelination in twitcher brains. The upregulation of L-PGDS was
more remarkable in perineuronal OLs than in interfascicular
OLs. A larger number of L-PGDS-positive OLs was found in
selected fiber tracts of twitcher brains where fewer apoptotic
cells were detected. The distribution of L-PGDS-positive OLs
was inversely related to the severity of demyelination, as as-
sessed by accumulation of scavenger macrophages. Mice dou-
bly deficient for L-PGDS and GALC disclosed a large number of
apoptotic neurons, which were never seen in twitcher brains, in
addition to an increased number of apoptotic OLs. A linear
positive correlation was observed between the population of
L-PGDS-positive OLs in the twitcher brain and the ratio of
apoptotic nuclei in the double mutant versus those in the
twitcher, suggesting a dose-dependent effect of L-PGDS
against apoptosis. These lines of evidence suggest that
L-PGDS is an anti-apoptotic molecule protecting neurons and
OLs from apoptosis in the twitcher mouse. This is a novel
example of OL–neuronal interaction.
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Prostaglandin (PG) D2 is a major PG in the CNS of rats, mice,
and humans, and functions as a neuromodulator of several central
actions, such as regulation of the sleep–wake cycle (Urade and
Hayaishi, 1999, 2000b; Hayaishi and Urade, 2002), body temper-
ature, hormone release, and pain responses (Eguchi et al., 1999).
In the CNS, PGD2 is mainly synthesized by lipocalin-type PGD
synthase (L-PGDS; Urade et al., 1985a; Ujihara et al., 1988).
Although L-PGDS is mainly expressed in the leptomeningeal
cells (Urade et al., 1993; Beuckmann et al., 2000), immunohisto-
chemistry and in situ hybridization revealed that L-PGDS is also
produced in oligodendrocytes (OLs) after commencement of
myelination in rats (Urade et al., 1987, 1993; Garcia-Fernandez et
al., 1997; Beuckmann et al., 2000), mice (Eguchi et al., 1999), and
humans (Blodorn et al., 1996). Because L-PGDS is not expressed
in Schwann cells of the peripheral nerve system, this protein is a
specific marker for mature OLs (Urade et al., 1985b).
The twitcher mouse (C57BL/6J-GALCtwi/twi), a homozygote
for a nonsense point mutation of the galactosylceramidase
(GALC) gene, is a model of the human genetic demyelinating
disease called globoid cell leukodystrophy (Duchen et al., 1980;
Wenger et al., 2000). The cause of demyelination in twitcher mice
has been suggested to be the result of an accumulation of the toxic
metabolite psychosine (Igisu and Suzuki, 1984b; Suzuki and Ta-
niike, 1995), leading to the dysfunction of myelin-forming cells,
i.e., OLs and Schwann cells. Because demyelination in the
twitcher brain progresses in an orderly manner (Taniike and
Suzuki, 1994), this mutant is a valuable model for investigating
the molecular events occurring in OLs during the demyelinating
process. The expression of OL markers, such as myelin basic
protein, myelin-associated glycoprotein, and proteolipid protein,
all decreased after the commencement of demyelination in the
twitcher brain (Taniike et al., 1998). We previously reported that
the depletion of OLs in the twitcher brain is caused by apoptosis
(Taniike et al., 1999).
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Because L-PGDS is expressed in normal mature OLs, we
investigated L-PGDS expression in the twitcher brain during the
demyelination process. Unexpectedly, we found that expression
of L-PGDS was upregulated in twitcher brains. Furthermore, we
found that the distribution of L-PGDS OLs and the severity of
demyelination were in inverse relationship. Thus, we hypothe-
sized that upregulation of L-PGDS may suppress apoptosis of
OLs, since demyelination is secondary to the apoptosis of OLs in
the twitcher brains. We finally confirmed the anti-apoptotic role
of L-PGDS by generating double-mutant, L-PGDS-deficient (L-
PGDS/) twitcher (GALCtwi/twi) mice.
MATERIALS AND METHODS
Animals. All animal experiments were performed according to the Jap-
anese Law for the Protection of Experimental Animals and also con-
formed to the regulations issued by the National Institutes of Health and
the Society for Neuroscience. Twitcher heterozygous pairs (GALCtwi/,
the inbred C57BL/6J-twi strain) were originally purchased from Jackson
Laboratory (Bar Harbor, ME), and the mutation was maintained by
interbreeding of known heterozygous mice. L-PGDS/ mice were gen-
erated through gene targeting technology (Eguchi et al., 1999) and
backcrossed to the inbred C57BL/6J strain. Southern blot and/or PCR
analysis of DNA prepared from clipped tails was conducted as previously
described (Sakai et al., 1996; Eguchi et al., 1999). For the detection of
wild-type or mutant alleles of L-PGDS, 5 primer (P1: 5-TGTCAGGA-
ATGTGGTATGCTC-3) was used together with either P2 (5-
AATACAGCTTTCTTCTCCCGGAAC-3) or P3 (5-GTAGCCGGA-
TCAAGCGTATGC-3) primers.
For generation of double mutant mice (L-PGDS/GALCtwi/twi),
L-PGDS/ C57BL/6J offspring (L-PGDS/GALC/) were mated
with L-PGDS/GALCtwi/ to create F1 (L-PGDS/GALC/ and
L-PGDS/GALCtwi/). Of the F2 litters produced by mating of
F1, L-PGDS/GALCtwi/ were mated with each other to produce
L-PGDS/GALCtwi/twi F3. Control L-PGDS/GALCtwi/twi F3 were
produced by mating L-PGDS/GALCtwi/ F2 mice. These two types of
F3 mice thus produced were subjected to the analysis. The frequency of
the each genotype in all generations conformed to Mendelian inheri-
tance patterns.
Materials. Rabbit polyclonal and rat monoclonal anti-mouse L-PGDS
antibodies were raised and purified as described previously (Eguchi et al.,
1999). Preabsorbed antibody was prepared by incubation of polyclonal
antibody with an excess amount of purified recombinant L-PGDS. These
antibodies were used at a dilution of 1:1000. The other antibodies used
were as follows: rabbit polyclonal anti-mouse pi-form of glutathione
S-transferase (pi-GST) antibody (1:1000; Biotrin International, Dublin,
Ireland), rabbit polyclonal anti-mouse carbonic anhydrase II (CA II)
antibody (1:1000; a generous gift from Dr. W. Cammer, Department of
Neuroscience, Albert Einstein College of Medicine), rabbit polyclonal
anti-cow glial fibrillary acidic protein (GFAP) antibody (prediluted;
Dako, Glostrup, Denmark), rabbit polyclonal anti-S-100 antibody (1;
1000; DAKO), rat monoclonal anti-mouse F4/80 antibody (1:400; Sero-
tec, Oxford, UK), and mouse monoclonal anti-rat microtubule-associated
protein 2 (MAP2) antibody (1:200; Sigma, St. Louis, MO). Biotinylated
Ricinus communis-agglutinin-1 (RCA-1; 50 g/ml) was purchased from
Vector Laboratories (Burlingame, CA).
RNA isolation, electrophoresis, and hybridization. Under deep ether
anesthesia, mice were killed at postnatal day 15 (P15), P20, P30, and P45.
Entire brains or brains divided into cerebellum and cerebrum were used.
When indicated, leptomeninges and choroid plexus were removed under
a dissecting microscope. The brains were quickly frozen in liquid nitro-
gen, with subsequent total RNA isolation by the guanidinium thiocya-
nate–phenol–chloroform method (Chomczynski and Sacchi, 1987). To-
tal RNA (10 g) was electrophoresed in an agarose gel, transferred to
Zeta Probe nylon membranes (Bio-Rad Laboratories, Hercules, CA),
and hybridized with 32P-labeled cDNA probes specific for mouse
L-PGDS (Eguchi et al., 1999), mouse CA II, or mouse glyceraldehyde-
3-phosphate dehydrogenase (G3PDH). The blots were visualized by
autoradiography with Kodak XAR-5 film and an intensifying screen.
The relative amount of each transcript was estimated by quantifying the
associated radioactivity with the BAS-2000 system (Fuji film, Tokyo,
Japan).
In situ hybridization. Paraffin sections of mouse brains were hybridized
with 35S- or digoxigenin-labeled antisense riboprobe for mouse L-PGDS
as previously described (Urade et al., 1993; Gerashchenko et al., 1998).
Signal specificity was assessed by incubation of adjacent sections with the
labeled sense riboprobe.
Measurement of L-PGDS activity and psychosine content in brain.
L-PGDS activity was determined in mouse brains with 40 M [1- 14C]
PGH2 in the presence of 1 mM dithiothreitol (Urade et al., 1985a).
Protein concentrations were determined by use of bicinchoninic acid
reagent (Pierce, Rockford, IL) with bovine serum albumin used as the
standard by following the manufacturer’s protocol. The level of psycho-
sine in mouse brains was measured by the method previously described
(Igisu and Suzuki, 1984a).
Immunohistochemistry, lectin histochemistry, and
terminal deoxynucleotidyl transferase-mediated
biotinylated UTP nick end labeling staining
We used four mice per genotype for each age for immunohistochemical
analysis for L-PGDS. Under deep ether anesthesia, mice were briefly
perfused through the left cardiac ventricle with physiological saline
followed by 4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH
7.4). Their brains were immediately removed, postfixed overnight in the
same solution, and processed for paraffin embedding.
The immunohistochemical results with a polyclonal rabbit antibody
and a monoclonal rat antibody against mouse L-PGDS (Eguchi et al.,
1999) were basically the same. Therefore, monoclonal antibody was used
in most cases because of lower background staining. Deparaffinized and
hydrated sections (5-m-thick) were preincubated with 0.3% H2O2 in
methanol followed by PBS containing 0.2% Triton X-100. After pretreat-
ment with trypsin for 15 min, the sections were sequentially incubated
with L-PGDS antibody, appropriate biotinylated secondary antibody,
and avidin–biotin complex (ABC; Vector Laboratories) according to the
manufacturer’s protocol. Immunoreactivity was visualized with 0.03%
H2O2 solution in 50 mM Tris-HCl, pH 7.6, containing 0.05% diamino-
benzidine (Dotite, Kumamoto, Japan).
For double immunostaining, anti-pi-GST/CA II, GFAP/S-100, and
F4/80 antibodies were used to identify OLs, astrocytes, and microglia–
macrophages, respectively (Tansey and Cammer, 1991; Toyooka et al.,
1993; Taniike and Suzuki, 1995). Deparaffinized sections were incubated
at 4°C overnight with one of these primary antibodies together with
anti-mouse L-PGDS antibody. Rat anti-L-PGDS antibody was used in all
cases except for the staining combined with F4/80, in which case rabbit
L-PGDS antibody was used. Sections were then reacted with Texas
Red-conjugated anti-rabbit IgG antibody (2 g/ml; ICN Biomedicals,
Aurora, OH) and biotin-conjugated anti-mouse IgG antibody (Vector
Laboratories) for 2 hr, followed by FITC-conjugated avidin D (2 g/ml;
Vector Laboratories) for 2 hr. Absence of cross-reactivity between
secondary antibodies was confirmed by omission of either primary anti-
body. All sections were observed under an Axiovert 100M microscope
connected to a Zeiss laser-scanning microscope 510 (Carl Zeiss,
Oberkochen, Germany).
For RCA-1 lectin histochemistry, after pretreatment with 3% H2O2
and 0.1% bovine serum albumin, deparaffinized sections were incubated
with biotinylated RCA-1 in PBS for 30 min. The incubation with ABC
and the visualization of horseradish peroxidase activity were performed
as described (Toyooka et al., 1993).
Terminal deoxynucleotidyl transferase-mediated biotinylated UTP
nick end labeling (TUNEL) histochemistry combined with immunohis-
tochemistry for pi-GST or MAP2 was performed as described (Taniike
et al., 1999). In the case of MAP2 staining, pretreatment with a mouse-
on-mouse immunodetection kit (Vector Laboratories) was necessary.
Electron microscopy. After fixation with 3% glutaraldehyde and 1%
paraformaldehyde in 0.1 M PB, pH 7.2, followed by postfixation with 1%
osmium tetrahydroxide, coronally cut brains were routinely processed
and examined. After observation of 1-m-thick semithin sections stained
with Toluidine blue, areas for ultrathin sections were selected and cut.
Ultrathin sections of the cerebellar hemisphere were stained with uranyl
acetate and lead citrate and examined with a JEM-100CX electron
microscope (JEOL, Tokyo, Japan) at 80 kV.
Cell counts and statistical analysis. L-PGDS  cells and TUNEL  cells
were counted in paraffin sections prepared from mice at P35 and P45, six
mice at each time. L-PGDS  cells were counted in 45-d-old L-PGDS/
GALCtwi/twi brain parenchyma.
Statistical comparisons were made by Student’s t test. Values of p 
0.05 were considered to be significant.
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RESULTS
Upregulation of L-PGDS in OLs of GALC twi/twi mice
Figure 1A shows that L-PGDS mRNA in GALCtwi/twi brains
increased progressively after P30 when demyelination was already
obvious (Taniike and Suzuki, 1994), whereas its level in wild-type
(GALC/) brains had already reached a plateau by P30. It
reached a level 1.7 times higher in GALCtwi/twi than in GALC/
by P45. In contrast, mRNA for CA II, which is a myelin/OL-
associated protein, did not increase after P20 in GALCtwi/twi
brains and was 61% of the GALC/ level at P45. L-PGDS
activities in mouse brains at P39 were as follows (mean  SE,
n  4): GALC/ cerebrum, 0.27  0.05 nmol  min1  mg1 pro-
tein; GALCtwi/twi cerebrum, 0.72  0.06 nmol  min1  mg1
protein; GALC/ cerebellum, 0.28  0.04 nmol  min 1 
mg 1 protein; GALCtwi/twi cerebellum, 0.74  0.11 nmol 
min1  mg1 protein. Thus, L-PGDS activity was significantly
increased in both cerebrum ( p  0.005) and cerebellum ( p 
0.01) in GALCtwi/twi as compared with that in GALC/.
To exclude the possibility that the increase in L-PGDS in
GALCtwi/twi brains was attributable to its increased production in
leptomeninges and choroid plexus, we compared the expression
level of L-PGDS mRNA between brains with and without lepto-
meninges (Fig. 1B). The level of L-PGDS mRNA in GALCtwi/twi
cerebral parenchyma without leptomeninges (designated as “P”
in Fig. 1B) increased fivefold to eightfold as compared with that
of GALC/ mice, whereas the levels in isolated leptomeninges
and choroid plexus (designated as “L” in Fig. 1B) and in whole
cerebellum (“C” in Fig. 1B) increased only 10–40% in GALCtwi/twi
mice. The upregulation of L-PGDS mRNA in the GALCtwi/twi
brain parenchyma was also confirmed by in situ hybridization
(Fig. 1C–E). Except for its presence in leptomeninges, L-PGDS
mRNA was undetectable in either GALC/ or GALCtwi/twi
Figure 1. Upregulation of mRNA for
L-PGDS in GALCtwi/twi OLs. A, North-
ern blot analysis for L-PGDS, CA II,
and G3PDH. W and T represent
GALC/ and GALCtwi/twi, respec-
tively. Postnatal days are indicated at
the top of the columns. The corrected
values (/G3PDH) are shown in the lower
graph. B, Northern blot analysis for
L-PGDS and G3PDH in brain paren-
chyma without leptomeninges and cho-
roid plexus ( P), the isolated leptome-
ninges and choroid plexus (L), and the
whole cerebellum (C) from two mouse
brains at P30. W-1 and W-2 are
GALC/, and T-1 and T-2 are GAL-
Ctwi/twi. C–H, In situ hybridization for
L-PGDS mRNA in coronal mouse brain
sections at P40 with 32P-labeled probe
(C–E) or digoxigenin-labeled probe (F–
H). C–E, Cerebellum and medulla.
DCN is indicated by asterisk in D. F–H,
GALCtwi/twi. F, The ventral part of the
forebrain. The leptomeninges (arrows)
as well as OLs (arrowheads) possess
mRNA for L-PGDS. G, Cerebellum.
Interfascicular OLs displaying strong
signals are indicated by arrowheads. The
astrocytes, having characteristically large
pale nuclei, are negative for L-PGDS
mRNA (small arrows). IG and CWM
represent the internal granular layer and
the cerebellar white matter, respectively.
H, Facial nuclei. Perineuronal OLs (neu-
rons are shown by n) show strong signals
for L-PGDS. Scale bars: C–E, 2 mm; F,
100 m; G, H, 20 m.
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brains before the onset of demyelination at P15 (data not shown).
The obvious leptomeningeal signal was recognized in both
GALC/ and GALCtwi/twi (Fig. 1C,D, F, arrows). In addition, at
P40 when demyelination had already advanced, a strong signal
was recognized throughout the cerebellar white matter and me-
dulla, particularly in the deep cerebellar nuclei (DCN) (Fig. 1D,
asterisk), in GALCtwi/twi. Higher magnification disclosed that the
intense signal was observed only in OLs in the GALCtwi/twi (Fig.
1F–H). L-PGDS mRNA was recognized in both interfascicular
OLs of the white matter (Fig. 1G) and perineuronal OLs of the
gray matter (Fig. 1H).
In GALC/, only a few L-PGDS perineuronal OLs were
detected throughout all ages examined (Fig. 2A,C, insets). In
contrast, in GALCtwi/twi brains, L-PGDS OLs were increased in
number in both the gray and white matter after P25, and many
cells with morphological features of degenerating OLs with mul-
tiple varicose processes (Taniike et al., 1999) showed intense
L-PGDS immunoreactivity at P40 (Fig. 2B,D, insets). The use of
the double immunofluorescence technique showed that
L-PGDS cells were positive for neither GFAP nor S-100, mark-
ers for astrocytes, nor for F4/80, a marker for microglia/macro-
phages (Taniike and Suzuki, 1995; data not shown). Confocal
images of GALCtwi/twi brains disclosed that all L-PGDS cells
were immunoreactive for CAII (Fig. 2E) or pi-GST (Fig. 2F,G)
and were thus identified as OLs (Taniike et al., 1999). In addition,
all perineuronal OLs were also immunoreactive for L-PGDS
(Fig. 2F, arrows), whereas interfascicular OLs were occasionally
L-PGDS (Fig. 2G, arrowheads). L-PGDS OLs were abundant
Figure 2. Increase in number of L-PGDS-
immunoreactive OLs in GALCtwi/twi brains
at P40. A, B, The primary motor area in the
forebrain. Scale bars: A, B, 200 m; insets,
20 m. C, D, DCN facing the fourth ventri-
cle. Scale bars: C, D, 100 m; insets, 5 m.
Arrows and arrowheads indicate L-PGDS 
cell somas and their varicose processes, re-
spectively, in a GALCtwi/twi brain. E–G,
Confocal images for the double immuno-
staining for L-PGDS ( green) and CAII (E,
red) or pi-GST (F, G, red) of the brainstem
(E), cerebral cortex (F), and corpus callo-
sum ( G) of GALCtwi/twi at P40. Arrows in
E–G and arrowheads in G indicate
L-PGDS  OLs and L-PGDS  OLs, re-
spectively. Scale bars, 10 m.
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in the DCN (Fig. 2D), cerebellar cortex, anterior commissure,
and optic nerve; but they were rare in the corpus callosum (Fig.
2G, arrows) and internal capsule, and L-PGDS was not detected
at any age examined in interfascicular OLs of the intermedullary
portion of the eighth nerve root (8n) and spinal trigeminal tract
(sp5) (Fig. 3A,E), which are sites of extensive demyelination in
GALCtwi/twi (Taniike and Suzuki, 1994).
These results clearly show that L-PGDS was upregulated in
GALCtwi/twi OLs in a region-specific manner.
Inverse relationship between the distribution of L-
PGDS OLs and the severity of demyelination in
GALCtwi/twi brains
Next we investigated the relationship between L-PGDS immuno-
reactivity and the severity of demyelination in GALCtwi/twi brains.
Figure 3 shows serial sections of the cerebellopontine angle region
(Fig. 3A–D) and the medulla (Fig. 3E,F) of the GALCtwi/twi at P40.
These regions were already described to be the most severely
demyelinated in GALCtwi/twi brains (Taniike and Suzuki, 1994).
Accumulation of RCA-1 scavenger macrophages, a pathological
hallmark of demyelination, was obvious in 8n (Fig. 3A,B, asterisks)
and in sp5 (Fig. 3E,F, asterisks), in which no L-PGDS OLs were
detected (Fig. 3A,E). On the contrary, a close-up view of the
interface between cerebellar white matter (CWM) (Fig. 3C,D,
asterisks) and DCN (Fig. 3C,D, daggers) revealed that very few
macrophages had infiltrated into the DCN where L-PGDS OLs
were abundant (Fig. 3C). These data clearly show that the regional
distribution profiles of L-PGDS OLs and macrophages were in
inverse relationship.
Apoptotic cells significantly increased in
L-PGDS/GALCtwi/twi brains
Because OL depletion and subsequent demyelination in
GALCtwi/twi are attributable to apoptosis of OLs (Taniike et al.,
1999), we predicted that L-PGDS may be upregulated in OLs to
provide resistance against the apoptosis and subsequent demyeli-
nation in GALCtwi/twi. To verify this hypothesis, we established a
mouse line doubly deficient for GALC and L-PGDS (Fig. 4).
Figure 3. Inverse relationship between
the distribution patterns of L-PGDS  cells
and microglia/macrophages in GALCtwi/twi
brains at P40. A–D, Cerebellopontine an-
gle. Asterisks indicate 8n in A and B. Scale
bars, 1 mm. C and D are higher magnifica-
tion views of the boxed areas in A and B,
respectively. Asterisks and daggers indicate
CWM and DCN, respectively. Scale bars,
50 m. E, F, Medulla. Asterisks indicate sp5.
Scale bars, 0.5 mm.
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There was no significant difference between L-PGDS/GAL-
Ctwi/twi and L-PGDS/GALCtwi/twi in terms of the life span
(50.3  0.3 d in L-PGDS/GALCtwi/twi vs 50.1  0.6 d in
L-PGDS/GALCtwi/twi; n  9). The neuropathology of both
genotypes was similar until P35. Psychosine, which is a potent
neurotoxin that accumulates in the GALCtwi/twi brain as a conse-
quence of the genetic defect, has been suggested to induce OL
dysfunction and apoptosis. The content of psychosine at P45 was
the same in the L-PGDS/GALCtwi/twi (cerebrum, 6.67  1.07
ng/mg protein; cerebellum, 22.74  6.87 ng/mg protein) and in
the L-PGDS/GALCtwi/twi (cerebrum, 7.68  1.92 ng/mg pro-
tein; cerebellum, 22.40  6.41 ng/mg protein) brains.
However, at P45, L-PGDS/GALCtwi/twi brains showed more
severe demyelination than the L-PGDS/GALCtwi/twi ones. At
P35, the number of TUNEL nuclei was already moderately
increased in the caudate–putamen and 8n of L-PGDS/
GALCtwi/twi brains; however, by P45, this number was drastically
increased in the L-PGDS/GALCtwi/twi brains (Fig. 4F,L) as
compared with the number in the L-PGDS/GALCtwi/twi ones
(Fig. 4C,I). In L-PGDS/GALCtwi/twi brains, TUNEL cells
Figure 4. Enhanced apoptosis and
macrophage aggregation in L-PGDS/
GALCtwi/twi . A, The restriction map for
the wild-type allele and the mutated
allele for L-PGDS. Restriction sites: P,
PvuII; N, NcoI; A, AcyI. Neor, neomycin
resistance gene. The combination of
P1/P2 primers or P1/P3 primers was
used to detect wild-type or null allele
for L-PGDS, respectively. GALC geno-
type was identified by the different
length of the EcoRV-digested fragments
of the PCR fragments; i.e., the twitcher
allele has a shorter fragment length.
B–G, Cerebellar cortex at P45. H–M,
DCN at P45. Scale bars, 100 m.
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were especially increased in number in the gray matter such as the
internal granular layer of the cerebellum (Fig. 4C,F, compare IG)
or DCN (Fig. 4, compare I, L). The number of apoptotic nuclei
was also increased in the white matter such as CWM (Fig. 4,
compare C, F) and corpus callosum. In both the DCN and IG of
L-PGDS/GALCtwi/twi brains, a large number of L-PGDS
perineuronal OLs was observed (Fig. 4B,H). In L-PGDS/
GALCtwi/twi brains, however, apoptotic cell death was accompa-
nied by many F4/80 activated microglia and/or infiltrating mac-
rophages in the IG (Fig. 4G) and DCN (Fig. 4M), where F4/80
cells were quite few (Fig. 4D,J) with very mild demyelination,
as previously described (Fig. 3, daggers), in the L-PGDS/
GALCtwi/twi brains.
Figure 5A summarizes the spatiotemporal distributional
change in RCA-1 microglia/macrophages, a pathological hall-
mark of demyelination (Taniike et al., 1994), and L-PGDS OLs
in the L-PGDS/GALCtwi/twi brains. In the most severely af-
fected areas such as the 8n or sp5, very few L-PGDS OLs were
observed throughout the ages examined. On the other hand, in
the least affected areas such as the lateral cerebellar nucleus (Fig.
5A, Lat) and dorsal cochlear nucleus (Fig. 5A, DC), L-PGDS
cells were found in abundance from the early stage of demyeli-
nation. Figure 5B summarizes the population of L-PGDS OLs
and apoptotic nuclei counted in seven brain regions. Because
perineuronal OLs tended to express more intense L-PGDS im-
munoreactivity than interfascicular OLs as described above, we
chose to analyze four regions from gray matter (cerebral cortex,
caudate–putamen, cerebellar cortex of anterior vermis, and
DCN) and two regions from white matter (corpus callosum and
8n). In addition, because the increase in number of TUNEL
nuclei was the most remarkable in the paraflocculus/flocculus of
cerebellum, the gray and white matter of this region was analyzed
as a whole. Whereas TUNEL nuclei density (nuclei /mm2) was
already significantly increased at P35 (Fig. 5B, top panel) in the
caudate–putamen (from 5.6  0.5 in L-PGDS/GALCtwi/twi to
18.3  5.0 in L-PGDS/GALCtwi/twi; p  0.05), and 8n (from
14.4  6.1 to 32.1  7.7; p  0.005), it was remarkably increased
at P45 (Fig. 5B, middle panel) in the DCN (from 36  5 in
L-PGDS/GALCtwi/twi to 183  32 in L-PGDS/GALCtwi/twi;
p  0.01), cerebellar cortex (from 47  3 to 251  32; p  0.05),
paraflocculus/flocculus (from 79  36 to 307  34; p  0.005),
caudate–putamen (from 333  34 to 603  54; p  0.01), and
corpus callosum (from 47  3 to 80  10; p  0.05). No significant
difference in the number of TUNEL nuclei was observed in the
cerebral cortex (31  5 and 40  2) and 8n (60  9 and 86  17)
between the respective L-PGDS/GALCtwi/twi and L-PGDS/
GALCtwi/twi brains at P45. The density of L-PGDS OLs (in cells
per square millimeter) in 45-d-old PGDS/GALCtwi/twi brains
(Fig. 5B, bottom panel) was high in DCN (153.4  6.2) and
cerebellar cortex (140.9  6.3), moderate in the paraflocculus/
flocculus (99.4  16.7) and corpus callosum (95.8  10.2), and low
in the cerebral cortex (35.3  1.3), caudate–putamen (15.0  1.5),
and 8n (1.8  1.8). When the ratio of apoptotic nuclei in
L-PGDS/GALCtwi/twi versus those in L-PGDS/GALCtwi/twi
Figure 5. Positive relationship between the re-
gional distribution of L-PGDS  OLs and the
increase in apoptotic cells caused by L-PGDS
deficiency. A, The population of RCA-1  micro-
glia/macrophages ( pink triangles in the lef t half )
and L-PGDS  cells (blue dots in the right half ) in
L-PGDS/GALCtwi/twi brains at P35 and P45.
Abbreviations: 7, facial nucleus; 8n, vestibuloco-
chlear nerve root; DC, dorsal cochlear nucleus;
Gi, gigantocellular reticular nucleus; GiA, gigan-
tocellular reticular nucleus ( part); IntA, inter-
posed cerebellar nucleus (anterior part); icp, in-
ferior cerebellar peduncle; Lat, lateral cerebellar
nucleus; Lve, lateral vestibular nucleus; Mve, me-
dial vestibular nucleus; py, pyramidal tract; RMg,
raphe magnus nucleus; scp, superior cerebellar
peduncle; sp5, spinal trigeminal tract; Sp5, spinal
trigeminal nucleus; VCP, ventral cochlear nu-
cleus (posterior part). B, The population of
TUNEL apoptotic nuclei (P35 and P45; hatched
columns, L-PGDS/GALCtwi/twi; open columns,
L-PGDS/GALCtwi/twi) and L-PGDS cells of
L-PGDS/GALCtwi/twi at P45 (solid columns) in
seven regions. *p  0.05; **p  0.01; ***p 
0.005. C, The ratio of the number of TUNEL 
cells in L-PGDS/GALCtwi/twi versus that in
L-PGDS/GA LCtwi/twi at P45 was plotted
against the population of L-PGDS  cells in
L-PGDS/GALCtwi/twi brains. r  0.875 ( p 
0.01).
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was plotted against the population of L-PGDS OLs in the
L-PGDS/GALCtwi/twi (Fig. 5C), a linear positive correlation
between these two parameters was observed, suggesting a dose-
dependent effect of L-PGDS against apoptosis. In addition, the
finding that apoptotic nuclei were more increased in number in
the gray matter (DCN, cerebellar cortex, caudate–putamen) than
in the white matter (corpus callosum and 8n) implies not only a
larger anti-apoptotic effect by perineuronal OLs than by interfas-
cicular OLs but also the possibility of neuronal apoptosis in
L-PGDS/GALCtwi/twi brains.
Neuronal apoptosis is induced in
L-PGDS/GALCtwi/twi
We chose the cerebellum for further analysis, because a large
number of TUNEL nuclei were recognized there. The obser-
vation of 1 m cerebellar sections disclosed many apoptotic
nuclei (Fig. 6B, white arrows) and the loss of granular cells in the
L-PGDS/GALCtwi/twi. Granular cells were present in a cluster
or a row in L-PGDS/GALCtwi/twi (Fig. 6A), whereas these cells
were often solitary in L-PGDS/GALCtwi/twi (Fig. 6B). In addi-
tion, the nuclear size of granular cells was much more variable
and usually smaller in L-PGDS/GALCtwi/twi than in L-PGDS/
GALCtwi/twi. The chromatin of L-PGDS/GALCtwi/twi granular
cells was condensed into fewer and larger nucleoli than that of
L-PGDS/GALCtwi/twi ones, making these nuclei lighter and
clearer (Fig. 6A,B, insets). These nuclear changes are suggestive
of the early phase of apoptosis. In the DCN, degenerating neu-
rons with a dark cytoplasm were frequently observed in
L-PGDS/ GALCtwi/twi brains (Fig. 6D, arrows) but not at all in
L-PGDS/GALCtwi/twi ones (Fig. 6C).
In the IG of L-PGDS/GALCtwi/twi, most of the TUNEL
cells were pi-GST (Fig. 7A) and MAP2 neurons (Fig. 7B),
whereas a considerable number of TUNEL cells in the CWM
and molecular layer (ML) (Fig. 7A, arrows) were identified as
pi-GST OLs. We observed no TUNEL cells in L-PGDS/
GALC/ and no MAP2 TUNEL cells in L-PGDS/
GALCtwi/twi (data not shown).
Electron microscopic investigation disclosed that many cells in
the IG of L-PGDS/ GALCtwi/twi brains showed nuclear changes
characteristic of apoptosis such as ruffled nucleoli or condensed
and clumpy chromatin beneath their nuclear membrane (Fig.
7C,E). Some of these apoptotic cells showed synaptic contact
(Fig. 7D, arrowheads), indicating them to be cerebellar granular
cells. A tubulovesicular structure was frequently visible in axons
in L-PGDS/ GALCtwi/twi (Fig. 7F, asterisk). These structures
have been reported to be present in cerebellum under diverse
experimental and pathological conditions, and they may represent
a stage in the degeneration of axonal collaterals and terminals
(for review, see Sotelo and Palay, 1971). Axons with these struc-
tures were also recognized in the L-PGDS/GALCtwi/twi cere-
bellum (7.3  4.7/100 myelinated axons), but were significantly
increased in number in L-PGDS/ GALCtwi/twi (33.4  3.6/100
myelinated axons; p  0.02), suggesting that axonal integrity was
perturbed in the L-PGDS/ GALCtwi/twi because of the loss of
axonal contact with apoptotic neurons.
From these lines of evidence, we concluded that the augmen-
tation of apoptosis in L-PGDS/GALCtwi/twi was caused by
disappearance of the anti-apoptotic function of L-PGDS.
L-PGDS produced by perineuronal OLs thus appears to play a
protective role against neuronal degeneration.
Figure 6. Degeneration and enhanced
apoptosis of cerebellar neurons in
L-PGDS/GALCtwi/twi brains at P45.
Semithin sections (1 m) stained with
Toluidine blue. A, B, The Purkinje cells
and IG. Apoptotic nuclei are indicated
by white arrows. C, D, DCN neurons.
Dark degenerating neurons are indi-
cated by arrows in D. Scale bars: 15 m;
insets, 5 m.
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DISCUSSION
L-PGDS as the first OL-associated protein upregulated
during demyelination
In this report, we demonstrate that L-PGDS expression is up-
regulated in GALCtwi/twi OLs with progressive demyelination
(Figs. 1, 2). As noted in other models of demyelination, such as
experimental autoimmune encephalomyelitis (Itoyama and Web-
ster, 1982; Yao et al., 1995), virus-induced demyelination (Rodri-
guez et al., 1994; Barac-Latas et al., 1997), and cuprizone intox-
ication (Fujita et al., 1990; Tansey et al., 1996; Morell et al., 1998),
the expression of myelin/OL-associated proteins, such as CA II
(Fig. 1A), myelin basic protein, myelin-associated glycoprotein,
proteolipid protein, and UDP–galactose:ceramide galactosyl-
transferase was downregulated after the commencement of de-
myelination in GALCtwi/twi (Taniike et al., 1998). The expression
of pi-GST, another OL-associated protein, remained constant
during demyelination in GALCtwi/twi (Taniike et al., 1999). Be-
sides the possible upregulation of apoptosis-associated proteins
such as caspases, L-PGDS is the first non-apoptosis-associated
protein demonstrated to be upregulated in OLs during progres-
sive demyelination. In a recent report, L-PGDS was the second
most abundant gene upregulated in the brains of patients with
multiple sclerosis (Chabas et al., 2001). Moreover, our prelimi-
nary data strongly suggested that L-PGDS was upregulated in
active lesions in mice with experimental autoimmune encephalo-
myelitis (data not shown). These findings suggested that the
upregulation of L-PGDS was a common phenomenon among the
demyelinating diseases, regardless of their primary etiology.
Because of the inverse correlation between L-PGDS OLs
and the severity of demyelination in GALCtwi/twi brains (Fig. 3),
Figure 7. Most apoptotic cells in the
L-PGDS/GALCtwi/twi cerebellum at
P45 were neurons. A, B, TUNEL histo-
chemistry. P and ML represent the Pur-
kinje cell layer and molecular layer,
respectively. Pi-GST TUNEL  cells
representing apoptotic OLs are indi-
cated by arrows in A. A MAP2 
TUNEL  cell is indicated by the arrow-
head in B. Scale bar, 20 m. C–F, Elec-
tron micrographs. D is a higher magni-
fication view of the boxed area in C. An
axosomatic synaptic contact between
the apoptotic cell and the neighboring
axon is indicated by the arrowheads in
D. An apoptotic cell in E, indicated by
an asterisk, is surrounded by apparently
intact internal granular layer neurons. A
tubulovesicular structure (asterisk) is
seen in F. Scale bars: C, E, F, 1 m; D,
0.2 m.
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we hypothesized an anti-apoptotic function of upregulated
L-PGDS in the CNS. However, the evaluation was made complex
by the presence of a considerable number of hematogeneous cells,
which infiltrate into GALCtwi/twi brains after P30 (Wu et al., 2000)
and secrete apoptotic cytokines such as TNF- in GALCtwi/twi
white matter (K. Shimono, Y. Fujitani, I. Mohri, M. Taniike, and
Y. Urade, unpublished observations). The reason why the num-
ber of L-PGDS cells was not simply inversely related to the
number of apoptotic nuclei in either L-PGDS/GALCtwi/twi or
L-PGDS/GALCtwi/twi brains might be explained by the pres-
ence of a significant number of apoptotic macrophages as well as
apoptotic effects of TNF-.
For example, in the caudate–putamen or the white matter of
the paraflocculus/flocculus, where TNF- expression was high
with a lot of infiltrating macrophages, the number of TUNEL
nuclei was unproportionally high. Even in these regions, the
anti-apoptotic effect of L-PGDS was obvious, and the TUNEL
nuclei increased in L-PGDS/GALCtwi/twi. On the other hand,
in the regions with minimal cellular infiltration such as DCN or
cerebellar cortex, TUNEL nuclei increased multi-fold in
L-PGDS/GALCtwi/twi when compared with their number in
L-PGDS/GALCtwi/twi.
The distribution of L-PGDS OLs was region specific.
TUNEL nuclei-rich areas in L-PGDS/ GALCtwi/twi brains at
P45 such as 8n or caudate–putamen contained only a small
number of L-PGDS cells, and vice versa for TUNEL nuclei-
poor areas such as the VCA or DCN (Fig. 5A,B). As compared
with the number in L-PGDS/GALCtwi/twi, the number of apo-
ptotic cells in L-PGDS/GALCtwi/twi increased in 35-d-old as
well as 45-d-old mice (Figs. 4, 5B,C). From these lines of evi-
dence, we verified the anti-apoptotic function of upregulated
L-PGDS in the CNS. In 8n or caudate–putamen of L-PGDS/
GALCtwi/twi brains, the number of L-PGDS OLs was constantly
small, whereas the number of apoptotic OLs recognized as
TUNEL pi-GST cells (Taniike et al., 1999) remarkably in-
creased in an age-dependent manner. Thus, we concluded that
the upregulation of L-PGDS does not simply reflect an ongoing
apoptosis in OL but possibly reflects heterogeneity of OL sub-
populations with regard to L-PGDS inducibility.
The dysfunction of Schwann cells leading to peripheral demy-
elination is the principal cause of death in GALCtwi/twi mice
(Taniike et al., 1994). L-PGDS was neither expressed in Schwann
cells of GALC/ nor induced in those of GALCtwi/twi, and there
was no significant difference in the life span between the
L-PGDS/GALCtwi/twi and L-PGDS/GALCtwi/twi mice.
Possible anti-apoptotic mechanisms of L-PGDS
Because L-PGDS is a bifunctional protein acting as a PGD2-
producing enzyme and as a lipophilic ligand-carrier protein of the
lipocalin family (Urade and Hayaishi, 2000a), there are at least
two possibilities for its anti-apoptotic mechanism, as discussed
below.
PGD2 elicits its biological actions through binding to the Gs-
coupled D-type PG receptor (DPR; Mizoguchi et al., 2001) or to
the Gi-coupled CRTH2 receptor (Hirai et al., 2001). Otherwise,
PGD2 is dehydrated to yield the J series of PGs such as 15-deoxy-
12,14-PGJ2 in vitro, which has been identified as a ligand for
peroxisome proliferator-activated receptor- (PPAR-; Forman
et al., 1995; Kliewer et al., 1995). PGD2 increases intracellular
cAMP through its binding to DPR (Hirata et al., 1994). The
increased cAMP prevents oligodendroglial excitotoxicity and the
eventual death of these cells (Yoshioka et al., 1998). Thus, PGD2
produced by upregulated L-PGDS in perineuronal OLs may
protect these cells from apoptosis by an increase in intracellular
cAMP levels mediated via DPR. CRTH2 is expressed in the
mouse brain (Abe et al., 1999), but its function and cellular
localization are still unknown. Although the natural occurrence
of 15-deoxy-12,14-PGJ2 in the brain remains to be clarified,
activation of PPAR- induces apoptosis in several cell lines
(Kawahito et al., 2000; Padilla et al., 2000; Rohn et al., 2001). It
is, therefore, worth studying the contribution of CRTH2 and
PPAR pathways to the apoptosis of OLs in GALCtwi/twi.
On the other hand, PGD2 inhibits the expression of inducible
nitric oxide synthase (iNOS) in vascular smooth muscle cells
(Nagoshi et al., 1998). iNOS induces demyelination and/or OL
apoptosis (Gilg et al., 2000; Liu et al., 2001; Molina-Holgado et
al., 2001) and apoptosis of cerebellar granular neurons (Minc-
Golomb et al., 1994, 1996; Sato et al., 1996). Many cerebellar
granular neurons showed apoptotic changes in L-PGDS/
GALCtwi/twi (Figs. 4, 6, 7); however, the upregulation of iNOS in
L-PGDS/GALCtwi/twi was not clearly recognized (data not
shown). Therefore, we do not consider iNOS to play a major role
in the neuronal apoptosis in GALCtwi/twi brains.
As a lipocalin, L-PGDS is secreted into the CSF and binds to
and transports small hydrophobic molecules such as biliverdin,
bilirubin, and retinoic acid (for review, see Urade and Hayaishi,
2000a). Therefore, L-PGDS may work as a scavenger of gliotoxic
and neurotoxic molecules to protect OLs and neurons from
degeneration. Psychosine is also a small hydrophobic molecule
and a potent neurotoxin that accumulates in GALCtwi/twi (Igisu
and Suzuki, 1984a,b); however, only weak affinity between
L-PGDS and psychosine was detected by surface plasmon reso-
nance spectroscopy (data not shown). In addition, psychosine
levels of L-PGDS/GALCtwi/twi and L-PGDS/GALCtwi/twi
brains were not significantly different, as described in Results. It
is, therefore, unlikely that L-PGDS is involved in scavenging
psychosine.
It was recently reported that L-PGDS induced apoptosis in
PC-12 cells (Ragolia et al., 2001) or pig kidney LLC-PK1 cells
(Maesaka et al., 2001). Moreover, the 24p3 protein, which is
another lipocalin evolutionally closely related to L-PGDS (Toh et
al., 1996), was reported to induce apoptosis of IL-3-deprived
hematopoietic cells (Devireddy et al., 2001). These lines of evi-
dence strongly suggested that L-PGDS may function as an apo-
ptotic or anti-apoptotic molecule depending on its concentration,
cell types, and so on. It is also possible that infiltrating macro-
phages produced PGs at a level high enough to induce apoptosis,
but that in the areas with little cellular infiltration, the moderate
amount of PGD2 released by OLs is served an anti-apoptotic role.
The anti-apoptotic mechanism of L-PGDS in GALCtwi/twi will be
clarified by a gene transfer experiment in which either the intact
L-PGDS or mutated L-PGDS gene, the latter encoding the
protein that has lost enzymatic activity and functions only as a
lipocalin, is injected to L-PGDS/GALCtwi/twi brains to see by
which construct the augmented apoptosis is restored to the
L-PGDS/GALCtwi/twi level.
Novel OL–neuronal interaction mediated by L-PGDS
As evident from our previous report that showed L-PGDS im-
munoreactivity in 8-week-old rat brains and not in 2-week-old
ones in active myelination (Urade et al., 1987), the function of
L-PGDS in OLs is unlikely to be linked to myelination but to
cellular maintenance. It is also noteworthy that the L-PGDS
immunoreactivity of perineuronal OLs in the gray matter was
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more intense than that of interfascicular myelinating OLs in the
white matter of 40-d-old L-PGDS/GALCtwi/twi mice (Fig. 2).
Only a few reports have proposed functions of perineuronal OLs:
Ludwin (1979, 1984) found that perineuronal OLs in the periven-
tricular gray remyelinated axons in cuprizone-induced or trauma-
induced demyelination and concluded that these OLs functioned
similarly as myelinating OLs. D’Amelio et al. (1990) demon-
strated that immunoreactivity for glutamine synthetase was dis-
tributed in perineuronal OLs as well as in astrocytes and that
perineuronal OLs fulfill a functional role more akin to that of
astrocytes. We propose here a novel function of perineuronal
OLs, i.e., protection of neurons from apoptosis by upregulation of
L-PGDS, which was most dramatically demonstrated in granular
cell neurons. This is a novel example of OL–neuronal interaction.
The results of this study not only cast a new light on the
function of perineuronal OLs but also have potentially important
implications for the treatment of neurodegenerative diseases as
well as the demyelinating disorders.
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